1026296-79-6

Basic information

• Product Name: 5-{N'-[(S)-3,5-difluoromandelyl]-L-valinyl}amino-7-cyclopropylmethyl-5,7-dihydro-6H-dibenz[b,d]azepin-6-one
• CAS NO: 1026296-79-6
• Molecular Weight: 533.618
• Mol File: 1026296-79-6.mol
• Article Data: 1

Chemical Properties

• CAS DataBase Reference: 5-{N'-[(S)-3,5-difluoromandelyl]-L-valinyl}amino-7-cyclopropylmethyl-5,7-dihydro-6H-dibenz[b,d]azepin-6-one(CAS DataBase Reference)
• NIST Chemistry Reference: 5-{N'-[(S)-3,5-difluoromandelyl]-L-valinyl}amino-7-cyclopropylmethyl-5,7-dihydro-6H-dibenz[b,d]azepin-6-one(1026296-79-6)
• EPA Substance Registry System: 5-{N'-[(S)-3,5-difluoromandelyl]-L-valinyl}amino-7-cyclopropylmethyl-5,7-dihydro-6H-dibenz[b,d]azepin-6-one(1026296-79-6)

Safety Data

• Hazardous Substances Data: 1026296-79-6(Hazardous Substances Data)

Upstream product

• 209982-91-2 S-(+)-3,5-difluoromandelic acid 

Relevant articles and documents

Cycloalkyl, lactam, lactone and related compounds, pharmaceutical compositions comprising same, and methods for inhibiting beta-amyloid peptide release and/or its synthesis by use of such compounds

Disclosed are compounds which inhibit β-amyloid peptide release and/or its synthesis, and, accordingly, have utility in treating Alzheimer's disease. Also disclosed are pharmaceutical compositions comprising a compound which inhibits β-amyloid peptide release and/or its synthesis as well as methods for treating Alzheimer's disease both prophylactically and therapeutically with such pharmaceutical compositions.